In addition, SOX2 that is a stem cell marker essential for the formation of pluripotent cells in the embryo13 is found to be up-regulated and activate signal transducer and activator of transcription 3 (STAT3) in melanoma cells resistant to BRAF-targeted therapy14. The gene discussed is BRAF; the disease is melanoma.